CAS: 127279-06-5
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | 4H-Pyrido[4',3':4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine, 6-(2-chlorophenyl)-9-(hexadecylsulfonyl)-7,8,9,10-tetrahydro-1-methyl- REF: IN-DA000WW1CAS: 127279-06-5 | - - - | A consultar | Ter 12 Nov 24 |
 | BN 50726 REF: TM-T71075CAS: 127279-06-5 | - - - | 1.660,00 €~2.826,00 € | Ter 14 Jan 25 |
![4H-Pyrido[4',3':4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine, 6-(2-chlorophenyl)-9-(hexad…](https://static.cymitquimica.com/products/IN/thumb/DA000WW1.jpg)
4H-Pyrido[4',3':4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine, 6-(2-chlorophenyl)-9-(hexadecylsulfonyl)-7,8,9,10-tetrahydro-1-methyl-
CAS:127279-06-5
Fórmula:
C34H48ClN5O2S2
Peso molecular:
658.3602
Ref: IN-DA000WW1
| Tamanho indefinido | A consultar |
Entrega estimada em Estados Unidos, Terça-feira 12 de Novembro de 2024
BN 50726
CAS:127279-06-5
BN 50726 is a platelet activating factor inhibitor; antagonizes PAF receptor binding.
Fórmula:
C34H48ClN5O2S2
Cor e Forma:
Solid
Peso molecular:
658.36
Ref: TM-T71075
| 25mg | 1.660,00 € | ||
| 50mg | 2.170,00 € | ||
| 100mg | 2.826,00 € |
Entrega estimada em Estados Unidos, Terça-feira 14 de Janeiro de 2025
